LEGN: Salovey Peter discloses securities transactions

By AlphaYouPublished Sep 28, 2026Form 4

Stocks in this disclosure

Reported activity

Salovey Peter

Reporting filer

Salovey Peter reported Grant or award in Legend Biotech Corp: 28330 units of Ordinary Shares, dated 2026-09-24. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 28, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Ordinary Shares	Salovey Peter	2026-09-24	A	Grant or award	28330	0	55,096	4 days	Filed terms security Title: Ordinary Shares id: F1 transaction Date: 2026-09-24 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 28330 id: F2 transaction Price Per Share: 0 transaction Acquired Disposed Code: A shares Owned Following Transaction: 55096 direct Or Indirect Ownership: D nature Of Ownership:

Ordinary Shares

Owner: Salovey Peter
Date: 2026-09-24
Code: A
Action: Grant or award
Quantity: 28330
Price: 0
Following holdings: 55,096
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Ordinary Shares
id: F1
transaction Date: 2026-09-24
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 28330
id: F2
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 55096
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Salovey Peter: Director.
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
F2: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Ordinary Shares

Salovey Peter

2026-09-24

Grant or award

28330

55,096

4 days

Filed terms

security Title: Ordinary Shares
id: F1
transaction Date: 2026-09-24
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 28330
id: F2
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 55096
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Salovey Peter: Director.

F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.